Whitehawk Therapeutics (WHWK) Accumulated Expenses (2018 - 2025)
Historic Accumulated Expenses for Whitehawk Therapeutics (WHWK) over the last 8 years, with Q3 2025 value amounting to $8.2 million.
- Whitehawk Therapeutics' Accumulated Expenses fell 4180.07% to $8.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.2 million, marking a year-over-year decrease of 4180.07%. This contributed to the annual value of $14.6 million for FY2024, which is 238.36% up from last year.
- According to the latest figures from Q3 2025, Whitehawk Therapeutics' Accumulated Expenses is $8.2 million, which was down 4180.07% from $5.4 million recorded in Q2 2025.
- Whitehawk Therapeutics' 5-year Accumulated Expenses high stood at $14.9 million for Q4 2022, and its period low was $677891.0 during Q2 2021.
- In the last 5 years, Whitehawk Therapeutics' Accumulated Expenses had a median value of $9.7 million in 2023 and averaged $9.6 million.
- Its Accumulated Expenses has fluctuated over the past 5 years, first skyrocketed by 120120.5% in 2021, then plummeted by 6060.65% in 2025.
- Over the past 5 years, Whitehawk Therapeutics' Accumulated Expenses (Quarter) stood at $8.7 million in 2021, then surged by 71.46% to $14.9 million in 2022, then fell by 4.13% to $14.3 million in 2023, then increased by 2.38% to $14.6 million in 2024, then tumbled by 43.91% to $8.2 million in 2025.
- Its last three reported values are $8.2 million in Q3 2025, $5.4 million for Q2 2025, and $8.6 million during Q1 2025.